More about

Thyroid Eye Disease

News
June 14, 2022
2 min watch
Save

VIDEO: Rise in glucose with drug therapy for thyroid eye disease ‘easily controlled’

VIDEO: Rise in glucose with drug therapy for thyroid eye disease ‘easily controlled’

ATLANTA — In this video exclusive, Terry Smith, MD, discusses results of an analysis of clinical trial data on blood glucose effects associated with teprotumumab therapy for thyroid eye disease.

News
April 04, 2022
1 min read
Save

Teprotumumab may provide better outcomes than IV methylprednisolone in thyroid eye disease

IV methylprednisolone was linked to a small change in proptosis from baseline compared with placebo in patients with thyroid eye disease, while teprotumumab may improve proptosis and diplopia vs. IV methylprednisolone.

News
March 23, 2022
2 min read
Save

Thyroid eye disease plus diabetes increases risk for sight-threatening complications

Thyroid eye disease plus diabetes increases risk for sight-threatening complications

Adults with thyroid eye disease and diabetes have a higher prevalence of diplopia, strabismus and sight-threatening disease compared with those without diabetes, according to study findings published in Endocrine Practice.

News
February 17, 2022
1 min watch
Save

VIDEO: Teprotumumab efficacy sustained after 6 months in thyroid eye disease

VIDEO: Teprotumumab efficacy sustained after 6 months in thyroid eye disease

AUSTIN, Texas — In this Healio Video Perspective from the North American Neuro-Ophthalmology Society meeting, Prem Subramanian, MD, PhD, discusses the sustained efficacy of teprotumumab in patients with thyroid eye disease.

News
January 03, 2022
2 min read
Save

Top 2021 thyroid news: Food and thyroid function, molecular testing for cancer and more

Top 2021 thyroid news: Food and thyroid function, molecular testing for cancer and more

The Healio and Endocrine Today editors have compiled the most popular thyroid news stories from 2021.

News
December 28, 2021
3 min read
Save

Endpoints for bone drugs, PCOS, transgender care and more: Cover stories in 2021

Endpoints for bone drugs, PCOS, transgender care and more: Cover stories in 2021

Endocrine Today editors have compiled the top cover stories published in 2021.

News
December 01, 2021
3 min watch
Save

VIDEO: 90% of patients in clinical trial adhere to teprotumumab

VIDEO: 90% of patients in clinical trial adhere to teprotumumab

NEW ORLEANS — In this Healio Video Perspective from the AAO meeting, Raymond Douglas, MD, PhD, discusses results of a clinical trial examining adherence to teprotumumab and reasons for nonadherence in patients with thyroid eye disease.

News
November 15, 2021
1 min read
Save

Teprotumumab may be effective in thyroid eye disease with less inflammation

Teprotumumab may be effective in thyroid eye disease with less inflammation

NEW ORLEANS — Teprotumumab may offer comparable proptosis efficacy in patients with thyroid eye disease with low levels of inflammation as seen in patients with higher levels of inflammatory activity, according to a study.

News
October 27, 2021
3 min read
Save

Teprotumumab effective long term, during retreatment for thyroid eye disease

Teprotumumab effective long term, during retreatment for thyroid eye disease

Teprotumumab is effective in reducing proptosis in people with thyroid eye disease more than 2 years after treatment, and initial nonresponders to teprotumumab may benefit from a second series of infusions, according to a speaker.

News
October 27, 2021
2 min read
Save

Proposed guideline focuses on individualized approach for thyroid eye disease

Proposed guideline focuses on individualized approach for thyroid eye disease

Treatment for thyroid eye disease should be personalized, with joint input from endocrinologists and ophthalmologists, according to two speakers.

View more